Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
HUMANIGEN, INC (HGEN)
Sector: Healthcare; Industry: Biotechnology

Humanigen, Inc., a biopharmaceutical company, develops proprietary monoclonal antibodies for immunotherapy and oncology treatments. The company's lead product candidate is Lenzilumab, a monoclonal antibody that targets and neutralizes granulocyte-macrophage colony-stimulating factor, which is in Phase I/II clinical trial in patients with chronic myelomonocytic leukemia, and for the treatment of juvenile myelomonocytic leukemia. Humanigen, Inc. was founded in 2000 and is based in Burlingame, California.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2015-12-16 BIESTEK MAREK Director Buy 10,000 $29.32 $293,200 No
2015-11-18 BIESTEK MAREK nan Buy 40,000 $2.04 $81,600 No
2015-11-17 BIESTEK MAREK nan Buy 200,000 $1.68 $335,450 No

Insider Smart

Planet Fitness, Inc (PLNT) - Our position in PLNT is also inspired by insider trading, if insiders are comfortable and confident buying around $50, it is an easy hold if you can pick it up at an even lower price. Our avg cost of the position is ~$40 and is now with 50% profit.